接種流感疫苗是預防流行性感冒的有效方法。每年WHO都會根據新分離出的毒株檢測數據以及上一個季節流感疫苗的性能選擇3-4種不同的流感毒株作為疫苗株。近幾十年，流感疫苗均為4價或者3價，可預防的流感包括1種H1N1、1種H3N2以及1種或者2種B型流感病毒（Yamagata 或/和 Victoria ）。
義翹神州ProVir病毒抗原庫中覆蓋了近600+流感病毒抗原，包括重組HA, NA, NP以及更多流感抗原，覆蓋了近些年WHO推薦的所有流感疫苗株，可用于檢測分析疫苗介導的抗體應答反應。除此之外，我們還開發了80余種流感病毒單克隆抗體試劑，可用于相關檢測試劑開發。
2021-2022流感疫苗株相關重組蛋白產品
| A/Victoria/2570/2019 (H1N1) Recommended for Egg-based (quadrivalent,trivalent) Vaccine HA: 40787-V08H, 40787-V08H1 NA: 40785-V08B NP: 40774-V08B |
A/Wisconsin/588/2019 (H1N1) Recommended for Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40787-V08H, 40787-V08H1 NA: 40785-V08B NP: 40774-V08B |
| B/Washington/02/2019 Recommended for Egg-based, Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40722-V08H NA: 40790-V08B NP: 40755-V08B |
B/Phuket/3073/2013 Recommended for Egg-based, Cell- or recombinant-based (quadrivalent) Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |
| A/Cambodia/E0826360/2020 (H3N2) Recommended for Egg-based, Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40789-V08H, 40789-V08H1 NA: 40784-V08B NP: 40778-V08B (Under Development) |
| A/Guangdong-Maonan/SWL1536/2019 (H1N1) Recommended for Egg-based (quadrivalent, trivalent) Vaccine HA: 40717-V08H NP: 40723-V08B |
A/Hong Kong/2671/2019 (H3N2) Recommended for Egg-based (quadrivalent, trivalent) Vaccine HA: 40721-V08H NP: 40753-V08B |
| A/Hawaii/70/2019 (H1N1) Recommended for Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40717-V08H NP: 40724-V08B |
A/Hong Kong/45/2019 (H3N2) Recommended for Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA:40765-V08H (Under Development) NP: 40754-V08B |
| B/Phuket/3073/2013 Recommended for Egg-based, Cell- or recombinant-based (quadrivalent) Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |
B/Washington/02/2019 Recommended for Egg-based, Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40722-V08H NP: 40755-V08B |
| A/Brisbane/02/2018 (H1N1) Recommended for Egg-based (quadrivalent) Vaccine HA: 40719-V08H NP: 40776-V08B |
A/Kansas/14/2017 (H3N2) Recommended for Egg-based (quadrivalent) Vaccine HA: 40720-V08H NP: 40779-V08B |
| B/Phuket/3073/2013 Recommended for Egg-based (quadrivalent) Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |
B/Colorado/06/2017 Recommended for Egg-based (quadrivalent); trivalent Vaccine HA: 40581-V08H NP: 40782-V08B (Under Development) |
| A/Michigan/45/2015 (H1N1) Recommended for quadrivalent Vaccine HA: 40567-V08H1 NA: 40568-V08B NP: 40777-V08B |
A/Singapore/INFIMH-16-0019/2016 (H3N2) Recommended for quadrivalent Vaccine HA: 40580-V08H NP: 40779-V08B |
| B/Colorado/06/2017 Recommended for quadrivalent; trivalent Vaccine HA: 40581-V08H NP: 40782-V08B (Under Development) |
B/Phuket/3073/2013 Recommended for quadrivalent Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |
| A/Michigan/45/2015 (H1N1) Recommended for trivalent Vaccine HA: 40567-V08H1 NA: 40568-V08B NP: 40777-V08B |
A/Hong Kong/4801/2014 (H3N2) Recommended for trivalent Vaccine HA: 40555-V08B NA: 40569-V08B NP: 40781-V08B |
| B/Brisbane/60/2008 Recommended for trivalent Vaccine HA: 40016-V08B NA: 40203-VNAHC NP: 40783-V08B (Under Development) |
B/Phuket/3073/2013 Recommended for quadrivalent Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |
| A/California/7/2009 (H1N1) Recommended for trivalent Vaccine HA: 11085-V08B NP: 40205-V08B |
A/Hong Kong/4801/2014 (H3N2) Recommended for trivalent Vaccine HA: 40555-V08B NA: 40569-V08B NP: 40781-V08B |
| B/Brisbane/60/2008 Recommended for trivalent Vaccine HA: 40016-V08B NA: 40203-VNAHC NP: 40783-V08B (Under Development) |
B/Phuket/3073/2013 Recommended for trivalent Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |
| A/California/7/2009 (H1N1) Recommended for trivalent Vaccine HA: 11085-V08B NP: 40205-V08B |
A/Switzerland/9715293/2013 (H3N2) Recommended for trivalent Vaccine HA: 40497-V08B NP: 40499-V08B |
| B/Brisbane/60/2008 Recommended for quadrivalent Vaccine HA: 40016-V08B NA: 40203-VNAHC NP: 40783-V08B (Under Development) |
B/Phuket/3073/2013 Recommended for trivalent Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |